Biology / Biotechnology Technology Offers

Leading Biology posted this:
Business Development Manager at Leading Biology

Anti-GPCR Antibody Production With rich experience in antibody discovery and membrane protein studies, experts from Leading Biology have launched a membrane protein antibody development platform. We provide a one-stop service of anti-GPCR membrane protein antibody discovery service against a variety of GPCR targets now.

Anti-GPCR Antibody Production

Covid-19 Innovation Challenges by Innoget posted this:

High-Throughput Sequencing Methods to Test Samples Highly parallel test for the presence of SARS-CoV-2 The currently used test for SARS-CoV2 virus uses molecular methods for detecting the presence of viral RNA sequences in subject samples. This is the approved gold standard in the field. The current application of this test requires several cumbersome steps that are labor intensive and require non-trivial reagents (which are becoming a global bottleneck). It is clear that during the next stage of managing the COVID19 pandemic, large scale testing will be needed. Project ID : 47-2020-10893

High-Throughput Sequencing Methods to Test Samples

Covid-19 Innovation Challenges by Innoget posted this:

Using Peptide Nucleic Acids (PNAs) as a Tool to Diagnose COVID-19 Using Peptide Nucleic Acids (PNAs) as a Tool to Diagnose COVID-19 We offer a fast and efficient diagnostic method which can be applied to a large amount of tests in a short time. Our method is based on a kit which identifies specifically the viral RNA biomarker. The test is characterized by reliability, sensitivity, rapid (not more than 10-15 minutes), low toxicity and reasonable cost. Project ID : 47-2020-10881

Using Peptide Nucleic Acids (PNAs) as a Tool to Diagnose COVID-19

Covid-19 Innovation Challenges by Innoget posted this:

Systematic Computational Drug Repositioning to Treat COVID-19 Systematic Computational Drug Repositioning to Treat COVID-19 The genetic revolution which has taken place in recent years brings new opportunities to the field of drug discovery & repositioning. Using advanced comparative genomic, and data integration, our lab has been developing a state-of-the-art AI algorithm which maps drug and food supplements that are useful in treating diseases and improving health conditions. To create this algorithm, we have been integrating and analyzing massive amounts of genomic data from 1,600 genomes, 14 thousand compounds, 20,000 human genes, and a comprehensive database of phenotypic data. Project ID : 47-2020-10880

Systematic Computational Drug Repositioning to Treat COVID-19

Covid-19 Innovation Challenges by Innoget posted this:

Fooling the Virus: A Fusion Protein as Virus-Specific Therapeutic Fooling the Virus: The Fusion protein as Virus-Specific Therapeutic An ACE2 A fusion protein of ACE2 with an Immunogenic Component Project ID : 47-2020-10877

Fooling the Virus: A Fusion Protein as Virus-Specific Therapeutic

Yissum - Research Development Company of the Hebrew University posted this:

Molecular Chip for Identification of Illegally Smuggled Wildlife Bushmeat Gila Kahila Bar-Gal - High Throughput Screening & Identification of Illegally smuggled Bushmeat – TTM 10815 - Currently there are thousands of tons of illigal meat from chimpanzees, elephant, giraffes etc. being smuggled into ports throughout Europe with no real way for identifying the origins of this meat. We have a solution for this and are seeking funding for building a molecular chip to help identify this illigal meat at the ports. Project ID : 47-2019-10815

Molecular Chip for Identification of Illegally Smuggled Wildlife Bushmeat

Yissum - Research Development Company of the Hebrew University posted this:

A METHOD FOR THE DIAGNOSIS AND TREATMENT OF COLORECTAL CANCER A METHOD FOR THE DIAGNOSIS AND TREATMENT OF COLORECTAL CANCER Project ID : 6-2019-9743

Yissum - Research Development Company of the Hebrew University posted this:

A Promising Agent for Coronavirus SARS-CoV-2 Infection therapy: Orally Available - Highly Potent Integrin avb3/avb5 Inhibitor A Promising Agent for Coronavirus SARS-CoV-2 Infection therapy: Orally Available - Highly Potent Integrin avb3/avb5 Inhibitor Project ID : 47-2020-10889

Yissum - Research Development Company of the Hebrew University posted this:

High-Throughput Sequencing Methods to Test Samples Highly parallel test for the presence of SARS-CoV-2 Project ID : 47-2020-10893

High-Throughput Sequencing Methods to Test Samples

Yissum - Research Development Company of the Hebrew University posted this:

A Universal Imaging tool to Test the Efficacy of Anti-Corona Drugs A Universal Imaging tool to Test the Efficacy of Anti-Corona Drugs Project ID : 47-2020-10896

A Universal Imaging tool to Test the Efficacy of Anti-Corona Drugs

Yissum - Research Development Company of the Hebrew University posted this:

Biological Control of Biofilms With Carriers Encapsulating Microbial Predators Amos Nussinovitch & Edouard Jurkevitch – Biological Control of Biofilms by Carriers Encapsulating Microbial Predators– (TTM #10882) – The researchers are developing a biodegradable functional system for delivering biocontrol agents to biofilms. The carriers are made of hydrocolloids which encapsulate a high concentration of Bdellovibrio like organisms (BALOs) which are known to fight biofilms. This system is environmentally friendly, prevents the target biofilm from developing resistance and the release rate of the biocontrol agents can be controlled. Technology Concept Formulated: Seeking Sponsored Research Funding Project ID : 47-2020-10882

Biological Control of Biofilms With Carriers Encapsulating Microbial Predators

Yissum - Research Development Company of the Hebrew University posted this:

Using Peptide Nucleic Acids (PNAs) as a Tool to Diagnose COVID-19 Using Peptide Nucleic Acids (PNAs) as a Tool to Diagnose COVID-19 Project ID : 47-2020-10881

Using Peptide Nucleic Acids (PNAs) as a Tool to Diagnose COVID-19

Yissum - Research Development Company of the Hebrew University posted this:

Systematic Computational Drug Repositioning to Treat COVID-19 Systematic Computational Drug Repositioning to Treat COVID-19 Project ID : 47-2020-10880

Yissum - Research Development Company of the Hebrew University posted this:

Fooling the Virus: A Fusion Protein as Virus-Specific Therapeutic Fooling the Virus: The Fusion protein as Virus-Specific Therapeutic An ACE2 A fusion protein of ACE2 with an Immunogenic Component Project ID : 47-2020-10877

Fooling the Virus: A Fusion Protein as Virus-Specific Therapeutic

Yissum - Research Development Company of the Hebrew University posted this:

Ultra-Low Dose Radiation for Repeat CT Scanning Ultra-Low Dose Radiation for Repeat CT Scanning Project ID : 46-2019-10755

1
2
3
4
5